Product Program year 2024 Source: CMS Open Payments

Acuvue Revitalens MPDS

Device

PDI 00827444001673

Open in the dashboard

General payments

$9,876

287 payments

Research payments

$0

0 payments

Through program year 2024, $9,876 in general payments and $0 in research payments were reported against Acuvue Revitalens MPDS.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $115 7
2023 General $351 18
2022 General $6,021 168
2021 General $3,389 94

Breakdown

Who paid General payments · program years 2021–2024
  1. Johnson & Johnson Vision Care, Inc. $9,537 272 payments
  2. Johnson & Johnson Surgical Vision, Inc. $323 14 payments
  3. Actelion Pharmaceuticals US, Inc. $16 1 payment
Top recipients General payments · program year 2024
  1. Daniel Chang Ophthalmology · Bakersfield, CA $95 82% · 6 payments
  2. Carlton Yuen Ophthalmology · Honolulu, HI $20 18% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Ophthalmology $115 100% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. California $95 82% · 1 recipient
  2. Hawaii $20 18% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

287 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record